DK0710653T3 - Nefazodonsalte med forbedrede opløsningshastigheder - Google Patents

Nefazodonsalte med forbedrede opløsningshastigheder

Info

Publication number
DK0710653T3
DK0710653T3 DK95307812.8T DK95307812T DK0710653T3 DK 0710653 T3 DK0710653 T3 DK 0710653T3 DK 95307812 T DK95307812 T DK 95307812T DK 0710653 T3 DK0710653 T3 DK 0710653T3
Authority
DK
Denmark
Prior art keywords
salts
nefazodone
dissolution rates
improved dissolution
dissolution
Prior art date
Application number
DK95307812.8T
Other languages
English (en)
Inventor
Hemant N Joshi
Terry D Wilson
Jatin M Patel
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK0710653T3 publication Critical patent/DK0710653T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK95307812.8T 1994-11-02 1995-11-01 Nefazodonsalte med forbedrede opløsningshastigheder DK0710653T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33339094A 1994-11-02 1994-11-02

Publications (1)

Publication Number Publication Date
DK0710653T3 true DK0710653T3 (da) 1997-12-08

Family

ID=23302579

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95307812.8T DK0710653T3 (da) 1994-11-02 1995-11-01 Nefazodonsalte med forbedrede opløsningshastigheder

Country Status (10)

Country Link
US (1) US6034085A (da)
EP (1) EP0710653B1 (da)
JP (1) JPH08208480A (da)
AT (1) ATE157659T1 (da)
AU (1) AU689645B2 (da)
CA (1) CA2160423A1 (da)
DE (1) DE69500652T2 (da)
DK (1) DK0710653T3 (da)
ES (1) ES2107280T3 (da)
GR (1) GR3025376T3 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091629A1 (en) * 1998-03-27 2003-05-15 Cima Labs Inc. Sublingual buccal effervescent
US20030118645A1 (en) * 1998-04-29 2003-06-26 Pather S. Indiran Pharmaceutical compositions for rectal and vaginal administration
US6974590B2 (en) * 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
ES2292238T3 (es) * 1998-04-24 2008-03-01 Scarista Limited Tratamiento de la depresion y preparaciones farmaceuticas para el mismo.
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
DE69930952T2 (de) * 1998-11-02 2006-08-31 Alza Corp., Mountain View Verfahren und Vorrichtung zur kontrollierten Abgabe pharmazeutischer Mittel sowie Dosierungsform hierfür
US7087372B2 (en) * 2001-01-18 2006-08-08 Idexx Laboratories, Inc. Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030129680A1 (en) * 2001-10-31 2003-07-10 O'connor Thomas Patrick Multi-analyte assay device
US7407770B2 (en) * 2001-01-18 2008-08-05 Idexx Corporation Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies
US20030194756A1 (en) * 2002-04-12 2003-10-16 O'connor Thomas Patrick Peptides for detection of antibody to Ehrlichia equi
US7183060B2 (en) * 2005-02-22 2007-02-27 Idexx Laboratories, Inc. Peptides for detection of antibody to Ehrlichia ewingii
US20030068356A1 (en) * 2001-07-10 2003-04-10 Pather S. Indiran Sequential drug delivery systems
GB0217056D0 (en) * 2002-07-23 2002-08-28 Ass Octel Use
TWI335218B (en) * 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
DE602004031771D1 (de) * 2003-12-31 2011-04-21 Cima Labs Inc Brauseformen von opiaten zur oralen anwendung und verfahren zur verabreichung von oxycodon
EP1708686B1 (en) * 2003-12-31 2011-02-16 Cima Labs Inc. Generally linear effervescent oral fentanyl dosage form and methods of administering
US7858121B2 (en) * 2003-12-31 2010-12-28 Cima Labs, Inc. Effervescent oral fentanyl dosage form and methods of administering fentanyl
US20060063735A1 (en) * 2004-09-17 2006-03-23 Supergen, Inc. Salts of 5-azacytidine
US20060069060A1 (en) * 2004-09-27 2006-03-30 Sanjeev Redkar Salts of decitabine
US7507789B2 (en) * 2007-04-09 2009-03-24 Idexx Laboratories, Inc. Detection of Anaplasma platys
EP2231696A4 (en) * 2007-09-21 2012-02-15 Idexx Lab Inc METHOD AND COMPOSITIONS FOR IDENTIFYING EHRLICHIA CHAFFEENSIS (VLPT)
MX2010002947A (es) * 2007-09-21 2010-08-04 Idexx Lab Inc Metodos y composiciones para deteccion de ehrlichia chaffeensis (p120).
WO2009070507A2 (en) 2007-11-27 2009-06-04 Idexx Laboratories, Inc. Anaplasma phagocytophilum (aph) antigens and antibodies specific for anaplasma
CA3018728A1 (en) * 2008-10-08 2010-04-15 Idexx Laboratories, Inc. Compositions and methods for detection of antibodies specific for anaplasma phagocytophilum (aph) and anaplasma platys (apl)
DK3045043T3 (da) 2009-02-26 2020-08-03 Relmada Therapeutics Inc Orale farmaceutiske sammensætninger af 3-hydroxy-n-methylmorphinan med forlænget frigivelse og fremgangsmåde til anvendelse
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
WO2013113000A2 (en) 2012-01-26 2013-08-01 Luc Montagnier Detection of dna sequences as risk factors for hiv infection
CN117797108B (zh) * 2024-01-02 2025-06-27 山东新时代药业有限公司 一种富马酸比索洛尔组合物片剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
IT1196429B (it) * 1986-07-01 1988-11-16 Mediolanum Farmaceutici Srl Processo per la preparazione di pirido benzotiazine ad attivita' antibatterica e loro sali con acidi solfonici
US5188836A (en) * 1990-07-27 1993-02-23 Warner-Lambert Company Sustained release formulations
TW279864B (da) * 1993-02-19 1996-07-01 Janssen Pharmaceutica Nv

Also Published As

Publication number Publication date
DE69500652D1 (de) 1997-10-09
ATE157659T1 (de) 1997-09-15
AU689645B2 (en) 1998-04-02
AU3458395A (en) 1996-05-09
US6034085A (en) 2000-03-07
CA2160423A1 (en) 1996-05-03
DE69500652T2 (de) 1998-02-19
EP0710653B1 (en) 1997-09-03
ES2107280T3 (es) 1997-11-16
GR3025376T3 (en) 1998-02-27
JPH08208480A (ja) 1996-08-13
EP0710653A1 (en) 1996-05-08

Similar Documents

Publication Publication Date Title
DE69500652D1 (de) Nefazodon-Salze mit verbesserter Auflösungsgeschwindigkeit
TR199600498A2 (tr) S(+)-ibuprofen'in oral formülasyonlari.
AR064896A2 (es) Composicion farmaceutica no higroscopica
DK1140088T3 (da) Orale methylphenidatformuleringer med reguleret/modificeret frigivelse
DK0498069T3 (da) Ny anvendelse af peptidderivat
DK0439030T3 (da) Orale lægemiddelformer af pimobendan
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
LU91290I2 (fr) Céfovécine, optionnellement sous la forme d'un sel, dont le sel de sodium (CONVENIAr)
IL98574A0 (en) Piperidyl-substituted indoles
FI951277A0 (fi) Uudet N,N,N',N'-tetrasubstituoituneet 1,2-etaanidiamiinijohdannaisyhdisteet
EA200400877A1 (ru) 2'-гало-3',5'-диалкоксифен-1'-илимино-2-имидазолидиновые производные и их применение для лечения недержания мочи
GB2135997B (en) N-(m-trifluoromethylphenyl)-n'-propargylpiperazine
TR199902117T2 (xx) (E)-4,6- Dikloro-3-(2-okso-1-fenilpirolidin-3-iliden metil)-1H-�ndol-2-karboksilik asidin kristalimsi hidratlanm�� sodyum tuzu.
DE69211161D1 (de) Antibiotische 7-aminonaphthazarinderivate
FR2798279B1 (fr) Dispositif d'insemination artificielle, notamment pour la reproduction des porcs
ES2086887T3 (es) Utilizacion de aguas madres de mareas salantes para la realizacion de una composicion de agua mar reconstituida.
DE3674060D1 (de) Pharmacologisch aktive propionylanilide.
DK336088A (da) Antitumormiddel opnaaet ved mikrobiel stereoselektiv reduktion af 4'-deoxy-4'-ioddoxorubicin
SE9101798D0 (sv) Sintrad karbonitridlegering med hoeg kvaevehalt